JCO Oncology Advances
محفوظ في:
| التنسيق: | Online |
|---|---|
| اللغة: | EN |
| منشور في: |
Wolters Kluwer Health - Lippincott Williams Wilkins
2025
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | 2994-9750 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| _version_ | 1869537440701612032 |
|---|---|
| collection | Directory of Open Access |
| format | Online |
| id | oai:doaj.orgir-journal:ad3bce20a7b747259d799b281d08e36d |
| institution | Directory of Open Access |
| language | EN |
| publishDate | 2025 |
| publishDateRange | 2025 |
| publishDateSort | 2025 |
| publisher | Wolters Kluwer Health - Lippincott Williams Wilkins |
| publisherStr | Wolters Kluwer Health - Lippincott Williams Wilkins |
| record_format | ojs |
| spelling | oai:doaj.orgir-journal:ad3bce20a7b747259d799b281d08e36d2026-01-15T10:33:32ZJCO Oncology Advances2994-9750https://doaj.org/toc/2994-9750ENCC BYCC BY-NC-NDWolters Kluwer Health - Lippincott Williams Wilkinshttps://ascopubs.org/authors/open-accesshttps://ascopubs.org/journal/oahttps://ascopubs.org/authorshttps://ascopubs.org/oa/about2025-09-08T10:09:44Zjournaloncologyglobal healthcancer researchclinical medicinecancerpublic healthNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282 |
| spellingShingle | oncology global health cancer research clinical medicine cancer public health Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 JCO Oncology Advances |
| title | JCO Oncology Advances |
| title_full | JCO Oncology Advances |
| title_fullStr | JCO Oncology Advances |
| title_full_unstemmed | JCO Oncology Advances |
| title_short | JCO Oncology Advances |
| title_sort | jco oncology advances |
| topic | oncology global health cancer research clinical medicine cancer public health Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
| topic_facet | oncology global health cancer research clinical medicine cancer public health Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
| url | 2994-9750 |